Search
for
Sort by
Research 331–360 of 647
- Adverse Cutaneous Reactions to Mood Stabilizers
- Endocrine-skin interactions
- Adverse Cutaneous Reactions to Antidepressants
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Side effects of common acne treatments
- Toxic shock syndrome: Recent developments in pathogenesis
- Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
- Epidermal Polarity Genes in Health and Disease
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy–like Autoimmune Disease
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Localization of varicella-zoster virus nucleic acids and proteins in human skin
- Alopecia as a rare but distinct manifestation of pemphigus vulgaris
- Expanding the Clinical and Mutational Spectrum of Recessive AEBP1-Related Classical-Like Ehlers-Danlos Syndrome
- An Update on Drug-Induced Pigmentation
- ADVANCES IN PSORIASIS THERAPY
- Kawasaki disease: an update
- REVIEW OF SO-CALLED ASEPTIC NEUTROPHILIC DERMATOSES
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Dermatologic Reactions to Targeted Therapy
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Stem cell apoptosis in HIV‐1 alopecia
- Radiation- and Chemotherapy-Induced Permanent Alopecia: Case Series
- The Significance of Scalp Involvement in Pemphigus: A Literature Review
- Soft Nails After Treatment With Aromatic Retinoids
- Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Novel therapies for alopecia areata: The era of rational drug development
- Cutaneous Crohn's disease treated with infliximab and 4 years of follow up